公司資料
Henry Schein 股價、新聞與催化劑
- 股票代碼:
- HSIC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
89.52 USD (-0.28%)
收盤價
最後更新: 2026年8月17日
8.66B USD
市值
股價為何變動
As of Aug 17, 2026, HSIC closed down 0.28% at $89.52. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Henry Schein is a global distributor of healthcare and dental products, with businesses spanning clinical supplies, equipment, and software. Its role is centered on healthcare distribution and practice support rather than biotech or medtech innovation.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Henry Schein has a global distribution footprint. It sits in healthcare distribution and dental supply rather than biotechnology.
商業模式特徵
The company generates revenue from product distribution, equipment sales, and software services for providers. Investors watch end-market demand, margin stability, and the health of dental and medical office spending.
生技產業定位
Henry Schein is outside biotech, but it is part of the healthcare infrastructure that keeps clinical and dental practices operating. It moves on distribution volumes and practice demand, not drug catalysts.
未來催化劑
- Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
- 01
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。